CN105498073A — 携带药物粒子的可降解植入导管
Assigned to First Affiliated Hospital of TMMU · Expires 2016-04-20 · 10y expired
What this patent protects
本发明公开了一种携带特定药物粒子(碘-125籽源及缓释药物颗粒如氟尿嘧啶缓释剂颗粒等)的可降解植入导管,包括用于容纳药物颗粒的导管本体和设于导管本体内的用于将药物间隔开来的间隔块,本发明的携带药物粒子的可降解植入导管,可装入足量的抗肿瘤药物并携带药物一同植入患者的肿瘤部位,通过使抗肿瘤药物颗粒得以在肿瘤内达到预定分布、不进入血管而被冲移位置,在瘤体含液及坏死腔隙仍能保持预定分布,导管降解后瘤体缩小时,植入药物颗粒可相应跟随肿瘤变化部位而不遗留在治疗部位外。
USPTO Abstract
本发明公开了一种携带特定药物粒子(碘-125籽源及缓释药物颗粒如氟尿嘧啶缓释剂颗粒等)的可降解植入导管,包括用于容纳药物颗粒的导管本体和设于导管本体内的用于将药物间隔开来的间隔块,本发明的携带药物粒子的可降解植入导管,可装入足量的抗肿瘤药物并携带药物一同植入患者的肿瘤部位,通过使抗肿瘤药物颗粒得以在肿瘤内达到预定分布、不进入血管而被冲移位置,在瘤体含液及坏死腔隙仍能保持预定分布,导管降解后瘤体缩小时,植入药物颗粒可相应跟随肿瘤变化部位而不遗留在治疗部位外。
Drugs covered by this patent
- Gemzar (Gemcitabine Hydrochloride) · Accord Hlthcare
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.